MPM BioImpact-Backed Aktis Seeks to Raise $212 Million in IPO
Aktis Oncology Inc., a clinical-stage biotechnology company focused on using so-called radiopharmaceuticals for treatments, is seeking to raise as much as $212
- Bloomberg Markets - Business